4.6 Article

Diagnostic Performance of [18F]FDG PET in Staging Grade 1-2, Estrogen Receptor Positive Breast Cancer

Related references

Note: Only part of the references are listed.
Article Oncology

FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact

Marianne Vogsen et al.

Summary: The study showed that FDG-PET/CT had a significant impact on staging and treatment changes in women with high-risk primary breast cancer, with incidental findings also considered clinically relevant.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer A Systematic Review and Meta-analysis

Sangwon Han et al.

Summary: The systematic review and meta-analysis found that the use of F-18-FDG PET, PET/CT, or PET/MRI during the initial staging of breast cancer can significantly modify staging and treatment plans for patients. Factors such as age, initial stage, and histologic grade were identified as significant factors affecting the heterogeneity in changes in stage or management. Routine clinical use of PET imaging for initial staging of breast cancer may be beneficial based on current literature.

CLINICAL NUCLEAR MEDICINE (2021)

Review Oncology

Oligometastatic breast cancer

Dorota Kwapisz

BREAST CANCER (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT

Deborah Pencharz et al.

BRITISH JOURNAL OF RADIOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET/CT for Staging and Restaging of Breast Cancer

David Groheux et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment

Gary J. R. Cook et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis

Yu Xiao et al.

NUCLEAR MEDICINE COMMUNICATIONS (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Ronald Boellaard et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

Review Radiology, Nuclear Medicine & Medical Imaging

Performance of FDG PET/CT in the Clinical Management of Breast Cancer

David Groheux et al.

RADIOLOGY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

David Groheux et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Review Oncology

Histological types of breast cancer: How special are they?

Britta Weigelt et al.

MOLECULAR ONCOLOGY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Retrospective Studyof 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data

Selin Carkaci et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Breast cancer staging in a single session: Whole-body PET/CT mammography

Till A. Heusner et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions

Ayse Mavi et al.

JOURNAL OF NUCLEAR MEDICINE (2007)

Article Oncology

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer

Rakesh Kumar et al.

BREAST CANCER RESEARCH AND TREATMENT (2006)

Article Radiology, Nuclear Medicine & Medical Imaging

FDG uptake in breast cancer:: correlation with biological and clinical prognostic parameters

A Buck et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)